Myeloid growth factors in oncology.

about

Myeloid growth factors in oncology.

Item

http://www.wikidata.org/entity/Q36181140

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

1998年论文

@zh

1998年论文

@zh-cn

name

Myeloid growth factors in oncology.

@ast

Myeloid growth factors in oncology.

@en

type

Item

label

Myeloid growth factors in oncology.

@ast

Myeloid growth factors in oncology.

@en

prefLabel

Myeloid growth factors in oncology.

@ast

Myeloid growth factors in oncology.

@en

P1476

Myeloid growth factors in oncology.

@en

P2093

Lofts FJ

http://www.w3.org/2001/XMLSchema#string

Pettengell R

http://www.w3.org/2001/XMLSchema#string

P2860

A comparison of peripheral blood stem cell mobilisation after chemotherapy with cyclophosphamide as a single agent in doses of 4 g/m2 or 7 g/m2 in patients with advanced cancer.

Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma.

Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison.

Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer.

Randomized double-blind prospective trial to evaluate the effects of sargramostim versus placebo in a moderate-dose fluorouracil, doxorubicin, and cyclophosphamide adjuvant chemotherapy program for stage II and III breast cancer.

Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin.

Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells.

Kinetics of human hemopoietic cells after in vivo administration of granulocyte-macrophage colony-stimulating factor.

Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B.

Defining a therapeutic dose of peripheral blood stem cells.

P304

1955-1976

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.7.12.1955

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1998-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15991939

http://www.w3.org/2001/XMLSchema#string

Myeloid growth factors in oncology.

about

Myeloid growth factors in oncology.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698